Quick Answer
AXIM BIOTECHNOLOGIES, INC. reported Gross Profit of $187.1 thousand for fiscal year 2018.
AXIM BIOTECHNOLOGIES, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2018 | $187.1K | +3867.4% |
| 2017 | $4.7K | +104.4% |
| 2016 | -$107.1K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | $15.7K | +58.5% | +58.5% |
| June 30, 2023 | $9.9K | — | -33.3% |
| June 30, 2021 | $14.9K | — | -80.6% |
| September 30, 2019 | $76.7K | +2416.8% | +1308.8% |
| June 30, 2019 | $5.4K | -7.6% | -57.0% |
| March 31, 2019 | $12.7K | +1.1% | +315.9% |
| September 30, 2018 | $3.0K | -62.4% | -48.3% |
| June 30, 2018 | $5.9K | +161.7% | -53.0% |
- AXIM BIOTECHNOLOGIES, INC. showed an increase of +3867.4% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2018 period, AXIM BIOTECHNOLOGIES, INC.’s gross profit has grown by 274.7% (from -$107.1 thousand to $187.1 thousand).
- The most recent figure is from AXIM BIOTECHNOLOGIES, INC.’s fiscal year 2018 report (Form 10-K), filed with the SEC on April 8, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: